These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31524351)

  • 21. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial.
    Shaarawy E; Hegazy RA; Abdel Hay RM
    J Cosmet Dermatol; 2015 Jun; 14(2):161-6. PubMed ID: 25810045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy and Safety of Botulinum Toxin Type A Injections in Improving Facial Scars: A Systematic Review and Meta-Analysis.
    Wang W; Liu G; Li X
    Pharmacology; 2022; 107(5-6):241-249. PubMed ID: 35354154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Treatment of Neuropathic Pain.
    Mittal SO; Safarpour D; Jabbari B
    Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study.
    Ziade M; Domergue S; Batifol D; Jreige R; Sebbane M; Goudot P; Yachouh J
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):209-14. PubMed ID: 23102873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralesional excision with topical intralesional cryotherapy improves the treatment of keloid scarring in a paediatric patient.
    Reissis D; Tickunas T; Agha RA; Greig A
    Ann R Coll Surg Engl; 2017 Nov; 99(8):e233-e335. PubMed ID: 29022793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
    Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
    Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Austin E; Koo E; Jagdeo J
    Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Botulinum Toxin Type A in Improving Scar Quality and Wound Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Guo X; Song G; Zhang D; Jin X
    Aesthet Surg J; 2020 Apr; 40(5):NP273-NP285. PubMed ID: 31155638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial.
    Huang RL; Ho CK; Tremp M; Xie Y; Li Q; Zan T
    Plast Reconstr Surg; 2019 Oct; 144(4):835-844. PubMed ID: 31568286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of keloids and hypertrophic scars. Pilot study with intralesional Lipotalon injections].
    Stark GB
    Fortschr Med; 1994 Mar; 112(8):109-12. PubMed ID: 8194821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids.
    Har-Shai Y; Amar M; Sabo E
    Plast Reconstr Surg; 2003 May; 111(6):1841-52. PubMed ID: 12711943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Safety and efficacy of botulinum toxin type A injection for postoperative scar prevention: A systematic review and meta-analysis.
    Yang W; Li G
    J Cosmet Dermatol; 2020 Apr; 19(4):799-808. PubMed ID: 31513335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical application and mechanism of botulinum toxin type A in scar treatment].
    Zhang YX; Zhang SN
    Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):705-710. PubMed ID: 34404162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cortisone jet injection as therapy of hypertrophic scars and keloids].
    Zanon E; Jungwirth W; Anderl H
    Handchir Mikrochir Plast Chir; 1992 Mar; 24(2):100-2. PubMed ID: 1582609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous botulinum toxin for chronic post-thoracotomy pain.
    Fabregat G; Asensio-Samper JM; Palmisani S; Villanueva-Pérez VL; De Andrés J
    Pain Pract; 2013 Mar; 13(3):231-4. PubMed ID: 22716282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional cryosurgery to treat keloid scars: results from a retrospective study.
    Chopinaud M; Pham AD; Labbé D; Verneuil L; Gourio C; Bénateau H; Dompmartin A
    Dermatology; 2014; 229(3):263-70. PubMed ID: 25248067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new argon gas-based device for the treatment of keloid scars with the use of intralesional cryotherapy.
    van Leeuwen MC; Bulstra AE; van Leeuwen PA; Niessen FB
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1703-10. PubMed ID: 25257046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars.
    Kang N; Sivakumar B; Sanders R; Nduka C; Gault D
    J Plast Reconstr Aesthet Surg; 2006; 59(7):693-9. PubMed ID: 16782564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the Treatment of Scars.
    González N; Goldberg DJ
    J Drugs Dermatol; 2019 Jun; 18(6):550-555. PubMed ID: 31251547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.